Shionogi invests 2.13 billion dollars to increase ViiV Healthcare stake as Pfizer exits
Shionogi & Co is increasing its stake in ViiV Healthcare to 21.7 percent through a 2.13 billion dollar share purchase while Pfizer exits the joint venture.
Insights:
Shionogi & Co Ltd , headquartered in JP 
JP, has announced a significant restructuring of its investment in ViiV Healthcare. The company will pay $2.13 billion for new shares, raising its total ownership stake to 21.7%. This move comes as US 
USpharmaceutical giant Pfizer Inc exits its 11.7% holding in the specialist HIV company for $1.88 billion.
JP, has announced a significant restructuring of its investment in ViiV Healthcare. The company will pay $2.13 billion for new shares, raising its total ownership stake to 21.7%. This move comes as US USpharmaceutical giant Pfizer Inc exits its 11.7% holding in the specialist HIV company for $1.88 billion.
